TECNTecan Group AG
133.20CHF-1.48%Mkt Cap: 1.69B CHFP/E: Last update: 2026-05-13

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)
P/E (Forward)17.28
PEG1.71
P/B1.47
P/S1.93
EV/EBITDA19.73
EV/Revenue1.81
EPS (TTM)-8.74
EPS (Forward)7.80
Cash Flow & Leverage
FCF Yield6.73%
FCF Margin12.86%
Operating CF137.98M CHF
CapEx (TTM)35.30M CHF
Net Debt/EBITDA-1.15
Net Debt-93.05M CHF
Technical
SMA 50128.83 (+3.4%)
SMA 200140.47 (-5.2%)
Beta1.01
S&P 52W Chg24.23%
Avg Vol (30d)53.50K
Avg Vol (10d)62.66K
Technical Indicators
RSI (14)55.0
MACD0.4045
MACD Signal-0.6171
MACD Hist.+1.0217
BB Upper145.49 CHF
BB Middle129.66 CHF
BB Lower113.84 CHF
BB Width24.41%
ATR (14)4.787 CHF
Vol Ratio (20d)0.68x
52W Range
110.6034% of range177.50
52W High177.50 CHF
52W Low110.60 CHF
Profitability
Gross Margin35.22%
EBITDA Margin9.16%
Profit Margin-12.54%
Oper. Margin4.93%
ROE-9.61%
ROA-6.52%
Revenue Growth-5.20%
Earnings Growth
Balance Sheet
Debt/Equity0.19
Current Ratio2.46
Quick Ratio1.69
Book Value/Sh91.87 CHF
Cash/Share24.84 CHF
Dividends
Fwd Div Rate3.000 CHF
Trail. Div Rate3.000 CHF
Div. Yield2.23%
5Y Avg Yield1.12%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Ownership
Shares Out.12.66M
Float12.50M
Insiders0.43%
Institutions63.09%
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)165.72 CHF
Target Range136.00 CHF205.00 CHF
# Analysts8
Company
Market Cap1.69B CHF
Enterprise Value1.60B CHF
Revenue (TTM)882.48M CHF
Gross Profit310.84M CHF
Net Income (TTM)-110.65M CHF
Revenue/Share69.69 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees3.0K
Last Price133.20 CHF
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN